United Kingdom · 
Who invested in Argonaute RNA?
Argonaute RNA's investors include Development Bank of Wales.
20252026
$2.3MVenture$1.8MVenture
United Kingdom · Venture startup
Who invested in Argonaute RNA
Funding summaryUpdated 26 Oct 2026
$4.1Mraised across 2 rounds since 2024, from 2 sources
$2.3MVenture$1.8MVenture
- Latest round
- Venture, $1.8MSept 2026
- Biggest round
- $2.3MVenture · Jul 2024
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $2.3M Jul 2024
- Biggest round
- $2.3M Venture · Jul 2024
- Between rounds
- 2.2 years from the last two
The rounds
- Sept 2026
- Jul 2024
Founders and team
From Argonaute RNA's own website: 18 on the team.
- Dr Mike KhanChief Executive Officer
- Dr Dan MitchellChief Scientific Officer
- Dr Stella PelengarisChief Medical Officer
- Dr Mark EdbrookeHead of Translational Research
- Dr Nigel RichardsonHead of Regulatory Affairs
- Alexander FinkNon-Executive Director
- Anthony ParkerExecutive Chairman
- David BallNon-Executive Director
- Dr Alex PatersonLead In-Silico Analyst
- Dr Gerda GasiunaiteLead Biomolecular Scientist
- Dr Johnathan MatlockNon-Executive Director
- Dr Mitchell GeerLead Biomolecular Scientist
- Dr Nabil Al-ChalabyNon-Executive Director
- Dr Owen CoxDirector Of Chemistry
- Dr Ross BurnNon-Executive Director
- Nigel DavisNon-Executive Director
- Peter Nowellfinance director
- Richard TompkinsNon-Executive DirectoR
AdvisersDr Andy Chapman
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Argonaute RNA
How much has Argonaute RNA raised?
Argonaute RNA has raised $4.1M across 2 rounds since 2024.
When did Argonaute RNA last raise?
Argonaute RNA's most recent round was a Venture of $1.8M in Sept 2026.
What was Argonaute RNA's biggest round?
Argonaute RNA's largest round on record is $2.3M (Venture), in Jul 2024.
Who backed Argonaute RNA first?
Argonaute RNA's first round on record, in Jul 2024, was backed by Development Bank of Wales.
What stage is Argonaute RNA at?
Argonaute RNA's latest named round is a Venture, in Sept 2026.
Where is Argonaute RNA based?
Argonaute RNA is based in the United Kingdom.
Companies like Argonaute RNA
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.